These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 25156648

  • 1. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
    Dollinger M, Jung EM, Beyer L, Niessen C, Scheer F, Müller-Wille R, Stroszczynski C, Wiggermann P.
    J Vasc Interv Radiol; 2014 Oct; 25(10):1589-94. PubMed ID: 25156648
    [Abstract] [Full Text] [Related]

  • 2. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M, Müller-Wille R, Zeman F, Haimerl M, Niessen C, Beyer LP, Lang SA, Teufel A, Stroszczynski C, Wiggermann P.
    PLoS One; 2015 Oct; 10(8):e0135773. PubMed ID: 26270651
    [Abstract] [Full Text] [Related]

  • 3. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.
    Dollinger M, Zeman F, Niessen C, Lang SA, Beyer LP, Müller M, Stroszczynski C, Wiggermann P.
    J Vasc Interv Radiol; 2016 Jan; 27(1):96-103. PubMed ID: 26777402
    [Abstract] [Full Text] [Related]

  • 4. Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
    Kingham TP, Karkar AM, D'Angelica MI, Allen PJ, Dematteo RP, Getrajdman GI, Sofocleous CT, Solomon SB, Jarnagin WR, Fong Y.
    J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820
    [Abstract] [Full Text] [Related]

  • 5. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
    Dollinger M, Beyer LP, Haimerl M, Niessen C, Jung EM, Zeman F, Stroszczynski C, Wiggermann P.
    Diagn Interv Radiol; 2015 Sep; 21(6):471-5. PubMed ID: 26359870
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Distelmaier M, Barabasch A, Heil P, Kraemer NA, Isfort P, Keil S, Kuhl CK, Bruners P.
    Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients.
    Niessen C, Beyer LP, Pregler B, Dollinger M, Trabold B, Schlitt HJ, Jung EM, Stroszczynski C, Wiggermann P.
    J Vasc Interv Radiol; 2016 Apr; 27(4):480-6. PubMed ID: 26922979
    [Abstract] [Full Text] [Related]

  • 10. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures.
    Froud T, Venkat SR, Barbery KJ, Gunjan A, Narayanan G.
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ, Vroomen LG, Nielsen K, van Tilborg AA, Comans EF, van Kuijk C, van der Meijs BB, van den Bergh J, van den Tol PM, Meijerink MR.
    BMC Cancer; 2015 Oct 24; 15():772. PubMed ID: 26497813
    [Abstract] [Full Text] [Related]

  • 13. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P, Nilsson A, Duraj F, Haglund U, Norén A.
    Eur J Surg Oncol; 2017 Apr 24; 43(4):751-757. PubMed ID: 28109674
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors.
    Sugimoto K, Moriyasu F, Saito K, Kobayashi Y, Itoi T.
    J Med Ultrason (2001); 2017 Jul 24; 44(3):247-254. PubMed ID: 27933441
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.
    Giorgio A, Amendola F, Calvanese A, Ingenito E, Santoro B, Gatti P, Ciracì E, Matteucci P, Giorgio V.
    J Ultrasound; 2019 Mar 24; 22(1):53-58. PubMed ID: 30843171
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Irreversible electroporation in porcine liver: acute computed tomography appearance of ablation zone with histopathologic correlation.
    Lee YJ, Lu DS, Osuagwu F, Lassman C.
    J Comput Assist Tomogr; 2013 Mar 24; 37(2):154-8. PubMed ID: 23493202
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.